Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology.
Saved in:
| Title: | Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology. |
|---|---|
| Authors: | Zhou Y; Clinical Immunology, Amgen Inc, South San Francisco, California, USA yanchenz@amgen.com., Penny HL; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Kroenke MA; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Bautista B; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Hainline K; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA., Chea LS; Clinical Immunology, Amgen Inc, South San Francisco, California, USA., Parnes J; Early Development, Amgen Inc, Thousand Oaks, California, USA., Mytych DT; Clinical Immunology, Amgen Inc, Thousand Oaks, California, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Apr; Vol. 10 (4). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
